TY - JOUR
T1 - Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis
AU - Lawlor, Kate E.
AU - Campbell, Ian K.
AU - O'Donnell, Kristy
AU - Wu, Li
AU - Wicks, Ian P.
PY - 2001/3/22
Y1 - 2001/3/22
N2 - Objective. To examine the molecular and cellular mechanisms in a model of acute inflammatory monarticular arthritis induced by methylated bovine serum albumin (mBSA) and interleukin-1 (IL-1). Methods. Mice were injected intraarticularly with mBSA on day 0 and subcutaneously with recombinant human IL-1β on days 0-2. At day 7, knee joints were removed and assessed histologically. Flow cytometry and RNase protection were used to analyze IL-1-dependent events. Results. C57BL/6 (B6), 129/Sv, and (B6 × 129/Sv)F1 hybrid mice, all H-2b strains, were susceptible to mBSA/IL-1-induced arthritis, whereas C3H/HeJ (H-2k) mice were not. B6 mice lacking T and B cells (RAG-1-/-) or major histocompatibility complex (MHC) class II antigens (MHCII-/-), and B6 mice treated with a CD4+ T cell-depleting monoclonal antibody, were resistant to disease. In contrast, B cell-deficient (μMT/μMT) mice developed arthritis at an incidence and severity similar to that of controls. RelB-deficient (RelB-/-) bone marrow chimeric mice had arthritis that was significantly reduced in incidence and severity. In B6 mice, flow cytometry demonstrated an IL-1-dependent leukocyte infiltration into the synovial compartment and RNase protection assays revealed induction of messenger RNA (mRNA) for the chemokines monocyte chemoattractant protein 1, macrophage inhibitory protein 2 (MIP-2), RANTES, MIP-1α, and MIP-1β, in vivo and in vitro. Conclusion. Arthritis induced by mBSA/IL-1 is strain specific and dependent on CD4+ T lymphocytes and at least partially on RelB, but not on B lymphocytes or antibody. IL-1 contributes to leukocyte recruitment to the synovium and directly induces chemokine mRNA production by synovial cells. This model of acute monarticular arthritis is particularly suitable for further investigations into cell-mediated immunity in arthritis and the role of IL-1.
AB - Objective. To examine the molecular and cellular mechanisms in a model of acute inflammatory monarticular arthritis induced by methylated bovine serum albumin (mBSA) and interleukin-1 (IL-1). Methods. Mice were injected intraarticularly with mBSA on day 0 and subcutaneously with recombinant human IL-1β on days 0-2. At day 7, knee joints were removed and assessed histologically. Flow cytometry and RNase protection were used to analyze IL-1-dependent events. Results. C57BL/6 (B6), 129/Sv, and (B6 × 129/Sv)F1 hybrid mice, all H-2b strains, were susceptible to mBSA/IL-1-induced arthritis, whereas C3H/HeJ (H-2k) mice were not. B6 mice lacking T and B cells (RAG-1-/-) or major histocompatibility complex (MHC) class II antigens (MHCII-/-), and B6 mice treated with a CD4+ T cell-depleting monoclonal antibody, were resistant to disease. In contrast, B cell-deficient (μMT/μMT) mice developed arthritis at an incidence and severity similar to that of controls. RelB-deficient (RelB-/-) bone marrow chimeric mice had arthritis that was significantly reduced in incidence and severity. In B6 mice, flow cytometry demonstrated an IL-1-dependent leukocyte infiltration into the synovial compartment and RNase protection assays revealed induction of messenger RNA (mRNA) for the chemokines monocyte chemoattractant protein 1, macrophage inhibitory protein 2 (MIP-2), RANTES, MIP-1α, and MIP-1β, in vivo and in vitro. Conclusion. Arthritis induced by mBSA/IL-1 is strain specific and dependent on CD4+ T lymphocytes and at least partially on RelB, but not on B lymphocytes or antibody. IL-1 contributes to leukocyte recruitment to the synovium and directly induces chemokine mRNA production by synovial cells. This model of acute monarticular arthritis is particularly suitable for further investigations into cell-mediated immunity in arthritis and the role of IL-1.
UR - http://www.scopus.com/inward/record.url?scp=0035097323&partnerID=8YFLogxK
U2 - 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M
DO - 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M
M3 - Article
C2 - 11229476
AN - SCOPUS:0035097323
SN - 0004-3591
VL - 44
SP - 442
EP - 450
JO - Arthritis & Rheumatology
JF - Arthritis & Rheumatology
IS - 2
ER -